Cargando…

Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation

This study aims to investigate US active duty (AD) military members diagnosed with atrial fibrillation (AF) and the temporal trends of systemic anticoagulation (AC). Our secondary objective is to study the AC prescriptions in AD military members diagnosed with AF and associated military dispositions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keithler, Andrea Nichole, Wilson, Andrew S, Yuan, Alexander, Sosa, Jose M, Bush, Kelvin N V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710344/ https://www.ncbi.nlm.nih.gov/pubmed/36446457 http://dx.doi.org/10.1136/bmjopen-2021-049394

Ejemplares similares

Characteristics of US military personnel with atrial fibrillation and associated deployment and retention rates
por: Keithler, Andrea Nichole, et al.
Publicado: (2023)

Characteristics of United States military pilots with atrial fibrillation and deployment and retention rates
por: Keithler, Andrea N., et al.
Publicado: (2022)

Temporal Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Atrial Fibrillation
por: Wu, Jing, et al.
Publicado: (2020)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
por: Adelakun, Adenike R, et al.
Publicado: (2023)

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

The Role of Catheter Ablation in Military Personnel with Atrial Fibrillation
por: Bush, Kelvin N V, et al.
Publicado: (2019)

Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study
por: Chen, Pei-Ti, et al.
Publicado: (2019)

Contemporary survival and anticoagulation of patients with atrial fibrillation: A community based cohort study in China
por: Wei, Yong, et al.
Publicado: (2022)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy
por: Marini, Massimiliano, et al.
Publicado: (2022)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
por: Apenteng, Patricia N, et al.
Publicado: (2018)

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2020)

World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
por: Murphy, Aileen, et al.
Publicado: (2020)

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation
por: Mai, Linlin, et al.
Publicado: (2019)

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation
por: Zawawi, Nur Azyyati, et al.
Publicado: (2021)

Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis
por: Wang, Dayang, et al.
Publicado: (2023)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Long-Term Efficacy and Anticoagulation Strategy of Left Atrial Appendage Occlusion During Total Thoracoscopic Ablation of Atrial Fibrillation to Prevent Ischemic Stroke
por: Kim, Ju Youn, et al.
Publicado: (2022)

Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Salmasi, Shahrzad, et al.
Publicado: (2020)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Lin, Dong, et al.
Publicado: (2021)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation
por: Huang, Hao, et al.
Publicado: (2022)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Elfar, Sohil, et al.
Publicado: (2022)

HAS-BLED vs. ORBIT scores in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis
por: Liu, Xuyang, et al.
Publicado: (2023)

Should We Maintain Anticoagulation after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation? The Need for a Randomized Study
por: Santarpia, Giuseppe, et al.
Publicado: (2017)

Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK
por: Han, Thang S, et al.
Publicado: (2018)

Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2021)

Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis
por: Shaikh, Fahad, et al.
Publicado: (2021)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6p4jqbch5od3ee94t364qlna2